Journal of Clinical Endocrinology & Metabolism, Vol 81, 2675-2679, Copyright © 1996 by Endocrine Society

ARTICLES

Regulation of human placental trophoblast low-density lipoprotein uptake in vitro by estrogen

RW Grimes, GJ Pepe and ED Albrecht
Department of Obstetrics/Gynecology, University of Maryland School of Medicine, Baltimore 21201, USA.

In the present study, human trophoblast cells were studied in culture to determine the effect of estrogen on low-density lipoprotein (LDL) uptake and progesterone formation. Cytotrophoblasts were obtained from term human placentas and incubated for 72 h with 10% FBS to stimulate formation of syncytia. Syncytiotrophoblasts were then incubated for an additional 48 h with estradiol and/or LDL protein. Estradiol plus LDL stimulated progesterone to a level that was 133% greater (P < 0.05) than control (314 +/- 69 ng/mg protein) or LDL alone, suggesting that estrogen stimulated progesterone formation via an increase in LDL uptake and utilization. To examine this possibility, trophoblast cells were cultured with estradiol for 48 h as above, then incubated for 12 h with 6-200 micrograms/mL [125I]LDL. Mean (+/- SE) specific uptake of [125I]LDL (ng/mg cell protein) was approximately 50% greater (P < 0.01) with estradiol (638 +/- 23) than with vehicle (429 +/- 54). Scatchard analysis demonstrated that the dissociation constant for LDL uptake was similar in the presence (2.9 +/- 0.4 x 10(-6)M) and absence (2.8 +/- 0.6 x 10(-8)M) of estradiol, indicating that estrogen increased LDL receptor number without affecting affinity. LDL uptake was increased (P < 0.05) by incubating trophoblast with as little as 0.10 ng/mL estradiol (approximately 10(-9) M). We conclude that estrogen regulates placental trophoblast cell uptake of LDL and, thus, the availability of cholesterol for progesterone bio-synthesis during human pregnancy.

This article has been cited by other articles:

				O. S. Descamps, M. Bruniaux, P.-F. Guilmot, R. Tonglet, and F. R. Heller Lipoprotein metabolism of pregnant women is associated with both their genetic polymorphisms and those of their newborn children J. Lipid Res., November 1, 2005; 46(11): 2405 - 2414. [Abstract] [Full Text] [PDF]

				P. Villaseca, C. Campino, E. Oestreicher, D. Mayerson, M. Seron-Ferre, and E. Arteaga Bilateral oophorectomy in a pregnant woman: hormonal profile from late gestation to post-partum: Case report Hum. Reprod., February 1, 2005; 20(2): 397 - 401. [Abstract] [Full Text] [PDF]

				W. Shi, K. F. Swan, S. R. Lear, J. S. O'Neil, S. K. Erickson, and M. C. Henson Regulation of Pathways Determining Cholesterol Availability in the Baboon Placenta with Advancing Gestation Biol Reprod, December 1, 1999; 61(6): 1499 - 1505. [Abstract] [Full Text]

				D. Chardonnens, P. Cameo, M.L. Aubert, F.P. Pralong, D. Islami, A. Campana, R.C. Gaillard, and P. Bischof Modulation of human cytotrophoblastic leptin secretion by interleukin-1{alpha} and 17{beta}-oestradiol and its effect on HCG secretion Mol. Hum. Reprod., November 1, 1999; 5(11): 1077 - 1082. [Abstract] [Full Text] [PDF]

				M. C. Henson, S. J. Greene, B. C. Reggio, W. Shi, and K. F. Swan Effects of Reduced Maternal Lipoprotein-Cholesterol Availability on Placental Progesterone Biosynthesis in the Baboon Endocrinology, April 1, 1997; 138(4): 1385 - 1391. [Abstract] [Full Text] [PDF]

				J. S. Babischkin, G. J. Pepe, and E. D. Albrecht Estrogen Regulation of Placental P-450 Cholesterol Side-Chain Cleavage Enzyme Messenger Ribonucleic Acid Levels and Activity During Baboon Pregnancy Endocrinology, January 1, 1997; 138(1): 452 - 459. [Abstract] [Full Text] [PDF]